We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TANVF market cap is 0. The company's latest EPS is TWD and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | |
| Total Revenue | 0 | 300k | 5.41M | 22.4M | 61.41M |
| Operating Income | -2.33B | -2.1B | -1.51B | -1.6B | -2.11B |
| Net Income | -2.27B | -2.1B | -1.54B | -1.64B | -2.14B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | |
| Total Assets | 3.57B | 4.37B | 4.71B | 3.42B | 2.76B |
| Total Liabilities | 542.12M | 1.75B | 1.92B | 2.03B | 1.94B |
| Total Equity | 3.03B | 2.62B | 2.79B | 1.39B | 821.11M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | TWD (TWD) | |
| Operating | -1.9B | -1.79B | -1.39B | -1.33B | -1.43B |
| Investing | 1.82B | -243.3M | -24.68M | -97.35M | -83.57M |
| Financing | 914.16M | 1.73B | 1.6B | -123.29M | 1.08B |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 133.96M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Tanvex Biopharma Inc (PK) |
| Address |
p.o box 31119, grand pavilion,hibiscus way,802 west bay road grand cayman |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
